Portrait of Garamendi, John

Garamendi, John

U.S. Representative CA-3 Democratic Party

Congressional stock trade history disclosed under the STOCK Act, parsed and scored by FilingIQ.

Disclosed trades
9
Buys / sells
11% / 89%
Last trade
Jan 14, 2022
Last filing
Jan 21, 2022

Latest disclosed trades

Latest 9 of 9
Ticker Type Traded
TWTR Sell Jan 14, 2022
GVA Sell Jan 14, 2022
FB Sell Jan 14, 2022
SQ Sell Jan 14, 2022
Health Fusion F ILING s TaTUs : Sell May 15, 2017
SZYM Sell Apr 21, 2017
HealthFusion F IlING s TaTus : N Sell Jan 21, 2016
SZYM Buy Jan 8, 2016
HealthFusion F IlING s TaTus : N Sell Jan 5, 2016

Amounts are reported as STOCK Act range buckets, not exact dollar values. Trade dates are the date the politician executed the trade; filing dates are when the disclosure was filed. Sign up to filter by ticker, amount range, or filing window, and to see the FilingIQ Score on every trade.

Garamendi, John stock trade activity

FilingIQ has indexed 9 congressional stock trade disclosures for Garamendi, John. The most recent disclosed transaction is dated Jan 14, 2022.

Across the full history, 1 purchases and 8 sales have been disclosed under the STOCK Act.

Top tickers traded by Garamendi, John

Frequently asked

How many stock trades has Garamendi, John disclosed?
FilingIQ tracks 9 Periodic Transaction Report disclosures for Garamendi, John, with the most recent dated Jan 14, 2022. Every entry sources back to the official House Office of the Clerk or Senate Office of Public Records.
Is Garamendi, John a net buyer or net seller?
Across the disclosed trade history, 1 (11%) were purchases and 8 (89%) were sales. Compensation and exchanges are filtered out of these counts.
Where does FilingIQ's data on Garamendi, John come from?
Every trade shown on this page is sourced from the STOCK Act disclosures filed with the House or Senate. FilingIQ normalizes ticker resolution, dates, and amount brackets across both chambers.

Methodology & sources

Disclosures parsed from official House Office of the Clerk and Senate Office of Public Records filings. Methodology documented on methodology. Compiled by Thomas Kraaibeek. Not investment advice; see disclaimer.